Around 1 in 6 people suffer from major depressive disorder at some point in their lives. Currently there is no way to predict the at-risk groups, but researchers at the University of Cambridge have been attempting to find biomarkers for use in adolescents.
Publishing in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), the researchers report their findings into early morning cortisol as a biomarker for depression in boys with high depressive symptoms.
Speakers:
Prof Ian Goodyer, Professor of Child & Adolescent Psychiatry, University of Cambridge (Prof Goodyer will be dialling in as he will be out of the country)
Prof Joe Herbert, Emeritus Professor of Neuroscience, John van Geest Centre for Brain Repair, University of Cambridge
Prof Barbara Sahakian, Professor of Clinical Neuropsychology at the Department of Psychiatry and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge